Major Depressive Disorder Clinical Trials

255 recruiting

Major Depressive Disorder Trials at a Glance

332 actively recruiting trials for major depressive disorder are listed on ClinicalTrialsFinder across 6 cities in 58 countries. The largest study group is Not Applicable with 167 trials, with the heaviest enrollment activity in New York, Toronto, and Boston. Lead sponsors running major depressive disorder studies include Centre for Addiction and Mental Health, Massachusetts General Hospital, and Icahn School of Medicine at Mount Sinai.

Browse major depressive disorder trials by phase

Treatments under study

About Major Depressive Disorder Clinical Trials

Looking for clinical trials for Major Depressive Disorder? There are currently 255 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Major Depressive Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Major Depressive Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 332 trials

Recruiting
Phase 2

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Major Depressive DisorderAnxiety Disorders
National Institute of Mental Health (NIMH)3,500 enrolled1 locationNCT00018057
Recruiting
Phase 2

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)
Draig Therapeutics Ltd300 enrolled40 locationsNCT07300969
Recruiting
Phase 1Phase 2

Personalized Ultrasonic Brain Stimulation for Depression (R61)

Depression - Major Depressive DisorderMajor Depressive EpisodeTreatment-Resistant Major Depressive Disorder
Brian Mickey30 enrolled1 locationNCT06902298
Recruiting
Phase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting
Not Applicable

CARED : A Novel Rapid Treatment Paradigm for Depression

Major Depressive Disorder
University of North Carolina, Chapel Hill30 enrolled1 locationNCT07507370
Recruiting

Natural History of Depression, Bipolar Disorder and Suicide Risk

Molecular Mechanisms of Pharmacological ActionDepressive SymptomsSuicide+17 more
National Institute of Mental Health (NIMH)500 enrolled1 locationNCT06462196
Recruiting
Phase 2

Mindfulness Engaged Neurostimulation for Depression (MEND II)

DepressionDepressive DisorderDepressive Symptoms+2 more
University of California, San Diego120 enrolled1 locationNCT07512284
Recruiting
Phase 4

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Major Depressive DisorderChronic Major Depression, Recurrent
University of Texas at Austin50 enrolled1 locationNCT05892744
Recruiting
Phase 1Phase 2

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

SchizophreniaMajor Depressive DisorderBipolar I Disorder
Mapi Pharma Ltd.24 enrolled6 locationsNCT07185815
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+7 more
Yale University200 enrolled2 locationsNCT06624137
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting
Phase 2

Neutralizing Interleukin (IL)-6

Major Depressive Disorder
Icahn School of Medicine at Mount Sinai60 enrolled1 locationNCT07493317
Recruiting

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study

Major Depressive DisorderBipolar DisorderMild Cognitive Impairment
Mayo Clinic200 enrolled1 locationNCT06897670
Recruiting
Phase 1

Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

DepressionHealthy VolunteerMajor Depressive Disorder
National Institute of Mental Health (NIMH)150 enrolled1 locationNCT03065335
Recruiting
Not Applicable

Maintenance rTMS for Depression (Maitr-De)

Major Depressive DisorderTreatment Resistant Depression
University of California, San Diego75 enrolled3 locationsNCT06938841
Recruiting
Not Applicable

TIS for NSSI in Adolescent Depression

Temporal Interference StimulationMajor Depressive DisorderNon Suicidal Self Injury
The Second Hospital of Anhui Medical University60 enrolled1 locationNCT07554755
Recruiting
Not Applicable

Defining Neurobiological Links Between Substance Use and Mental Illness

Substance Use DisorderNormal PhysiologyMajor Depressive Disorder
National Institute on Drug Abuse (NIDA)620 enrolled1 locationNCT05538910
Recruiting
Phase 3

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder
Neurocrine Biosciences850 enrolled87 locationsNCT06966401
Recruiting
Early Phase 1

Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine

Major Depressive Disorder (MDD)
University of Pennsylvania10 enrolled1 locationNCT06788249
Recruiting
Phase 1Phase 2

Neural Response to Inflammatory Challenge in Major Depressive Disorder

Major Depressive Disorder
Laureate Institute for Brain Research, Inc.180 enrolled1 locationNCT04751331